Suchergebnisse - "Wang, Yanxia"

PubPharm (13)

1

Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE) : a randomised, double-blind, double-dummy, active control, non-inferiority trial

enthalten in: The Lancet. Neurology | 2023

von Pan, Y. | Meng, X. | Yuan, B. | +128

CommentIn: Lancet Neurol. 2023 Jun;22(6):457-459. - PMID 37121238

2

Effect of Hypertension on Efficacy and Safety of Ticagrelor-Aspirin Versus Clopidogrel-Aspirin in Minor Stroke or Transient Ischemic Attack

enthalten in: Stroke | 2022

von Wang, A. | Meng, X. | Tian, X. | +18

3

Immunogenicity and safety of an egg culture-based quadrivalent inactivated non-adjuvanted subunit influenza vaccine in subjects ≥3 years : A randomized, multicenter, double-blind, active-controlled phase III, non-inferiority trial

enthalten in: Vaccine | 2022

von Zhang, Y. | Wang, Y. | Jia, C. | +21

4

Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children : Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial

enthalten in: Frontiers in immunology | 2022

von Xia, S. | Duan, K. | Zhang, Y. | +35

5

Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years : a randomised, double-blind, controlled, phase 1/2 trial

enthalten in: The Lancet. Infectious diseases | 2022

von Xia, S. | Zhang, Y. | Wang, Y. | +35

6

Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA

enthalten in: The New England journal of medicine | 2021

von Wang, Y. | Meng, X. | Wang, A. | +126

CommentIn: N Engl J Med. 2021 Dec 30;385(27):2576-2577. - PMID 34965343

7

Effect of Ginkgolide in Ischemic Stroke patients with large Artery Atherosclerosis : Results from a randomized trial

enthalten in: CNS neuroscience & therapeutics | 2021

von Dong, Y. | Zhang, J. | Wang, Y. | +62

8

Safety and immunogenicity of a quadrivalent inactivated subunit non-adjuvanted influenza vaccine : A randomized, double-blind, active-controlled phase 1 clinical trial

enthalten in: Vaccine | 2021

von Wang, Y. | Zhang, Y. | Wu, H. | +11

9

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV : a randomised, double-blind, placebo-controlled, phase 1/2 trial

enthalten in: The Lancet. Infectious diseases | 2021

von Xia, S. | Zhang, Y. | Wang, Y. | +29

10

Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes : Interim Analysis of 2 Randomized Clinical Trials

enthalten in: JAMA | 2020

von Xia, S. | Duan, K. | Zhang, Y. | +34

CommentIn: JAMA. 2020 Sep 8;324(10):943-945. - PMID 32789500